Retirement Systems of Alabama Lowers Position in Masimo Co. (NASDAQ:MASI)

Retirement Systems of Alabama lowered its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 52.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 54,035 shares of the medical equipment provider's stock after selling 60,225 shares during the period. Retirement Systems of Alabama owned about 0.10% of Masimo worth $8,932,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC grew its position in shares of Masimo by 41.2% in the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider's stock valued at $900,860,000 after buying an additional 1,970,883 shares during the last quarter. State Street Corp grew its position in shares of Masimo by 0.7% in the 3rd quarter. State Street Corp now owns 1,438,814 shares of the medical equipment provider's stock valued at $191,837,000 after buying an additional 10,179 shares during the last quarter. Westfield Capital Management Co. LP grew its position in shares of Masimo by 23.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider's stock valued at $185,869,000 after buying an additional 262,370 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Masimo by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 792,886 shares of the medical equipment provider's stock valued at $105,741,000 after buying an additional 11,984 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Masimo by 9.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 792,166 shares of the medical equipment provider's stock valued at $105,619,000 after buying an additional 70,440 shares during the last quarter. Institutional investors own 85.96% of the company's stock.

Masimo Stock Up 1.5 %

MASI stock traded up $2.61 during trading on Wednesday, reaching $179.51. 283,975 shares of the stock were exchanged, compared to its average volume of 461,296. The firm's 50 day moving average is $171.82 and its 200 day moving average is $148.33. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $183.14. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm has a market cap of $9.61 billion, a P/E ratio of 123.80 and a beta of 1.02.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on MASI shares. Wells Fargo & Company upped their price target on Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a research report on Wednesday, December 11th. Stifel Nicolaus restated a "buy" rating and set a $190.00 target price (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Piper Sandler upped their target price on Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a research report on Wednesday, December 18th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a research report on Wednesday, January 22nd. Finally, Raymond James upped their target price on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research report on Friday, December 27th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $191.40.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.